Plasma cytochrome c as a biomarker for mitochondrial toxicity during antiretroviral therapy
US-2015346213-A1 · Dec 3, 2015 · US
Biomarkers to identify HIV-specific T-cell subsets
US9164094B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9164094-B2 |
| Application number | US-201213452344-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 20, 2012 |
| Priority date | Oct 22, 2009 |
| Publication date | Oct 20, 2015 |
| Grant date | Oct 20, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to expression profiles of HIV-specific T-cells and their methods of use, including but not limited to treatment of HIV, increasing T-cell function and/or survival in HIV infected subjects, monitoring HIV disease progression and classifying HIV infected subjects as controllers or chronic progressors.
First claim
Opening claim text (preview).
What is claimed: 1. A method of classifying an immune response in an individual infected with HIV comprising: obtaining a biological sample from an individual infected with HIV; determining an expression profile of HIV specific T-cells from said HIV-infected individual by determining hybridization of a nucleic acid in said sample to a probe on a microarray, wherein said expression profile comprises an expression level of at least two genes selected from those presented in FIG.…
Assignees
Inventors
Classifications
Physics · mapped topic
Human Necessities · mapped topic
Physics · mapped topic
Physics · mapped topic
- G01N33/56988Primary
Physics · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9164094B2 cover?
- The invention relates to expression profiles of HIV-specific T-cells and their methods of use, including but not limited to treatment of HIV, increasing T-cell function and/or survival in HIV infected subjects, monitoring HIV disease progression and classifying HIV infected subjects as controllers or chronic progressors.
- Who is the assignee on this patent?
- Haining W Nicholas, Ebert Benjamin, Walker Bruce, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification G01N33/56988. Mapped technology areas include Physics.
- When was this patent published?
- Publication date Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).